Medicine
Tafluprost 0.0045 mg/0.3 mL eye drops
Tafluprost 0.0045 mg/0.3 mL eye drops is a generic prescription medicine for ophthalmic use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2º to 8°C (36º to 46°F). During shipment tafluprost…
Key facts
- Active ingredient (INN)
- Tafluprost
- Brand
- Sold under the generic name
- Strength
- 0.0045 mg/0.3 mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 pouch, 2 pouches, 6 pouches and 3 more
- Manufacturers
- Micro LabsIndiaIngenus PharmaceuticalsPrasco LaboratoriesSandoz
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2º to 8°C (36º to 46°F). During shipment tafluprost ophthalmic solution may be maintained at temperatures up to 40ºC (104ºF) for a period not exceeding 2 days. After the pouch is opened, the single-dose containers may be stored in the opened foil pouch for up to 30 days at room temperature 20º to 25°C (68º to 77°F). Store in the original pouch. Protect from moisture.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE05 Tafluprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 November 2022
- Identifiers
- RxCUI 1244611DailyMed set ID 5d766054-d13f-462c-bf8a-6462e56ca097, bfffa484-4105-45ec-ab1d-124e96639f35, 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368 +1NDC 50742-339, 0781-6184, 66993-429 +1Application ANDA218002, ANDA209040, NDA202514 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 15 vial in 1 pouch / .3 mL in 1 vial | 42571-264-26 | Micro LabsIndia | 18 November 2022 |
| 2 pouch in 1 carton / 15 vial in 1 pouch / .3 mL in 1 vial | 42571-264-73 | Micro LabsIndia | 18 November 2022 |
| 6 pouch in 1 carton / 15 vial in 1 pouch / .3 mL in 1 vial | 42571-264-74 | Micro LabsIndia | 18 November 2022 |
| 6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / .3 mL in 1 vial, single-dose | 50742-339-30 | Ingenus Pharmaceuticals | 18 December 2024 |
| 6 pouch in 1 carton / 5 container in 1 pouch / .3 mL in 1 container | 0781-6184-87 | Sandoz | 5 December 2022 |
| 3 pouch in 1 carton / 10 vial, single-use in 1 pouch / .3 mL in 1 vial, single-use | 66993-429-30 | Prasco Laboratories | 18 November 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 February 2012 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tafluprost
Clinical summary
Tafluprost is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops for ophthalmic use. MedsAcross supplies Tafluprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TafluprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZIOPTAN prescribing information (Thea Pharma) · U.S. National Library of Medicine, DailyMed
Need Tafluprost 0.0045 mg/0.3 mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.